ResMed Inc. Stock Rises Monday, Outperforms Market

Eaton Vance Tax-Managed Buy-Write Opportunities Fund

Change company Symbol lookup

Select an option...

XETVX Eaton Vance Tax-Managed Buy-Write Opportunities Fund

ENZC Enzolytics Inc

GREE Greenidge Generation Holdings Inc

MLM Martin Marietta Materials Inc

ERESW East Resources Acquisition Equity Warrant Exp 1st July 2027 *W EXP 07/01/2027

NRAC Noble Rock Acquisition Corp

DCGO DocGo Inc

VELOW Velocity Acquisition Equity Warrant Exp 24 Feb 2028 *W EXP 02/24/2028

MRC MRC Global Inc

BAC Bank of America Corp

Company profile

Eaton Vance Tax-Managed Buy-Write Opportunities Fund (the Fund) is a diversified closed-end management investment company. The Fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The Fund invests at least 80% of its total assets in a diversified portfolio of common stocks. The Fund invests primarily in common stocks of United States issuers. The Fund may invest approximately 10% of its total assets in securities of foreign issuers, including American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs) and European Depositary Receipts (EDRs). It invests in sectors, such as information technology, consumer discretionary, communication services, healthcare, financial services, industrials, consumer staples, utilities, energy, materials and real estate. Fund’s investment advisor is Eaton Vance Management (EVM). State Street Bank and Trust Company (SSBT) serves as a custodian of the Fund.

ResMed Inc. Stock Rises Monday, Outperforms Market

5:21 pm ET January 10, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of ResMed Inc. (RMD) inched 0.05% higher to $237.35 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.14% to 4,670.29 and Dow Jones Industrial Average falling 0.45% to 36,068.87. The stock's rise snapped a six-day losing streak. ResMed Inc. closed $63.99 short of its 52-week high ($301.34), which the company achieved on September 9th.

The stock underperformed when compared to some of its competitors Monday, as Thermo Fisher Scientific Inc. (TMO) rose 2.96% to $625.04, Medtronic PLC (MDT) rose 0.44% to $105.62, and Koninklijke Philips N.V. ADR (PHIA.AE) rose 1.48% to $38.33. Trading volume (490,190) eclipsed its 50-day average volume of 473,492.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 10, 2022.

-MarketWatch Automation

(END) Dow Jones Newswires

January 10, 2022 17:21 ET (22:21 GMT)